# Cat McDonald

> Cat McDonald is a seed investor at AlbionVC backing FinTech, Software and Health Care. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [AlbionVC](https://shizune.co/investors/profile/albion-vc)
- Total investments: 8
- Last investment: Aug 2025
- Lead investor: 63%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/cat-mcdonald-11188173

Cat McDonald is an Investment Manager at AlbionVC. She attended Harvard University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| FinTech | 2 | 25% |
| Software | 2 | 25% |
| Health Care | 2 | 25% |
| Cyber Security | 2 | 25% |
| Machine Learning | 2 | 25% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 38% |
| Series A | 2 | 25% |
| Series B | 2 | 25% |
| Venture - Series Unknown | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Innerworks | Innerworks is a cybersecurity company pioneering Synthetic Threat Intelligence to protect financial services from fraud, bots, and sanctioned actors. Its ethical hacking platform, RedTeam, continuously trains and improves detection models against the most advanced AI threats. Innerworks’ core product suite – bot detection, device fingerprinting,and geolocation intelligence – outperforms the top five market leaders in accuracy, enabling institutions to block malicious actors even if they return with new accounts or identities. Backed by leading firms across payments, cybersecurity & FinTech, Innerworks is setting a new standard in fraud defence for the AI era. | $4M | Seed | Aug 18, 2025 |  |
| TransFICC | TransFICC is an e-trading technology company providing low latency connectivity for banks and asset managers trading in Fixed Income and Derivatives markets. The company resolves the problem of fragmentation in the fixed income and derivatives markets. It does three things such as translates Execution Venue API’s to a single API. Clients connectonce to TransFICC's unified API, and TransFICC manages connectivity with the electronic venues from that point, uses low-latency, scalable and secure technology, essential to keep pace with price updates and not get beaten to trade by high-frequency trading firms, and provides timestamps for price and order messages. Measured in microseconds, timestamps record when data arrives at the bank or asset manager, helping to provide an audit trail, which supports Best Execution.TransFICC makes it easier to upgrade when venues change their application programming interfaces, compared with the enterprise systems of legacy firms, the firm claims. It also focuses solely on the business of providing market access.TransFICC was founded in 2016 and is based in London, England, United Kingdom. | $25M | Series B | Apr 09, 2025 |  |
| Healios | Founded in 2013, Healios is a leading digital healthcare technology company working to empower patients and families affected by mental and physical illnesses.Healios is pioneering how family intervention and behavioural change techniques are delivered beyond treatment team walls, to maximise patient and family outcomes. By blending the best oftechnology, specialised expertise and a personal human connection, they help patients and families develop a new level of understanding and sustain healthier habits over time. Their mission is to transform how care is delivered to help patients, families and carers effectively move forward and achieve their goals, providing a better quality of life. | $15.6M | Series B | Nov 03, 2022 |  |
| OutThink | OutThink is a cyber security start-up, headquartered in London, UK. Recognised by Gartner and Forrester for innovation, we transform the way companies engage with their employees to educate, change behaviours and build a risk aware culture. Our award-winning human risk management platform (SaaS) is built to identify and reduce risky workforcebehaviours. OutThink brings an innovative solution built by CISOs for CISOs, to help address the growing demand for fully trained employees in the fight against growing cyber threats. | $10M | Seed | Oct 18, 2022 |  |
| Ophelos | Ophelos was created to transform how individuals, families, and businesses manage their financial health. | $6.1M | Seed | Jun 29, 2022 |  |
| TransFICC | TransFICC is an e-trading technology company providing low latency connectivity for banks and asset managers trading in Fixed Income and Derivatives markets. The company resolves the problem of fragmentation in the fixed income and derivatives markets. It does three things such as translates Execution Venue API’s to a single API. Clients connectonce to TransFICC's unified API, and TransFICC manages connectivity with the electronic venues from that point, uses low-latency, scalable and secure technology, essential to keep pace with price updates and not get beaten to trade by high-frequency trading firms, and provides timestamps for price and order messages. Measured in microseconds, timestamps record when data arrives at the bank or asset manager, helping to provide an audit trail, which supports Best Execution.TransFICC makes it easier to upgrade when venues change their application programming interfaces, compared with the enterprise systems of legacy firms, the firm claims. It also focuses solely on the business of providing market access.TransFICC was founded in 2016 and is based in London, England, United Kingdom. | $17M | Venture - Series Unknown | Mar 30, 2022 |  |
| brytlyt | Brytlyt is the world’s first all-in-one browser-led platform that enables GPU in-database AI with deep learning capabilities. We aim to empower the next generation of data scientists and decision makers with accessible deep learning methods and data analytics at GPU speeds. | $5M | Series A | Dec 22, 2021 |  |
| Healios | Founded in 2013, Healios is a leading digital healthcare technology company working to empower patients and families affected by mental and physical illnesses.Healios is pioneering how family intervention and behavioural change techniques are delivered beyond treatment team walls, to maximise patient and family outcomes. By blending the best oftechnology, specialised expertise and a personal human connection, they help patients and families develop a new level of understanding and sustain healthier habits over time. Their mission is to transform how care is delivered to help patients, families and carers effectively move forward and achieve their goals, providing a better quality of life. | $9.9M | Series A | May 18, 2021 |  |

8 of 8 investments shown.

## Co-investors
- [InHealth Ventures](https://shizune.co/investors/profile/inhealth-ventures) — VC Fund, 4 deals together
- [Citi](https://shizune.co/investors/profile/citigroup) — VC Fund, 2 deals together
- [Fly Ventures](https://shizune.co/investors/profile/fly-ventures) — VC Fund, 2 deals together
- [HSBC](https://shizune.co/investors/profile/hsbc) — VC Fund, 2 deals together
- [Illuminate Financial](https://shizune.co/investors/profile/illuminate-financial) — VC Fund, 2 deals together
- [Neosfer](https://shizune.co/investors/profile/neosfer) — VC Fund, 2 deals together

## About AlbionVC

VC Fund · London, United Kingdom

AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/

5 contacts available at AlbionVC.

| Name | Title | Profile |
| --- | --- | --- |
| Adam Chirkowski | Partner | https://shizune.co/investors/profile/adam-chirkowski |
| Christoph Ruedig | Partner | https://shizune.co/investors/profile/christoph-ruedig |
| Ed Lascelles | Partner | https://shizune.co/investors/profile/ed-lascelles |
| Andrew Elder | Deputy Managing Partner | https://shizune.co/investors/profile/andrew-elder |
| Cat McDonald | Investment Manager | https://shizune.co/investors/profile/cat-mcdonald |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Cat McDonald invest in?

Cat McDonald invests primarily in FinTech, Software and Health Care startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cat McDonald last invest?

The most recent investment recorded for Cat McDonald closed in Aug 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co